POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors - PubMed
- ️Wed Jan 01 2003
. 2003 May 1;63(9):2244-50.
Hans Stoop, Hubert P J C de Leeuw, Carlos A de Gouveia Brazao, Ad J M Gillis, Kees E P van Roozendaal, Everardus J J van Zoelen, Rob F A Weber, Katja P Wolffenbuttel, Herman van Dekken, Friedemann Honecker, Carsten Bokemeyer, Elizabeth J Perlman, Dominik T Schneider, Juha Kononen, Guido Sauter, J Wolter Oosterhuis
Affiliations
- PMID: 12727846
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors
Leendert H J Looijenga et al. Cancer Res. 2003.
Abstract
Human germ cell tumors (GCTs) may have variable histology and clinical behavior, depending on factors such as sex of the patient, age at clinical diagnosis, and anatomical site of the tumor. Some types of GCT, i.e., the seminomas/germinomas/dysgerminomas and embryonal carcinomas (the stem cell component of nonseminomas), have pluripotent potential, which is demonstrated by their capacity to differentiate into somatic and/or extraembryonic elements. Although embryonal carcinoma cells are intrinsically pluripotent, seminoma/germinoma/dysgerminoma cells, as well as their precursor carcinoma in situ/gonadoblastoma cells, have the phenotype of early germ cells that can be activated to pluripotency. The other types of GCT (teratomas and yolk sac tumors of infants and newborn, dermoid cyst of the ovary, and spermatocytic seminoma of elderly) are composed of (fully) differentiated tissues and lack the appearance of undifferentiated and pluripotent stem cells. OCT3/4, a transcription factor also known as OTF3 and POU5F1, is involved in regulation of pluripotency during normal development and is detectable in embryonic stem and germ cells. We analyzed the presence of POU5F1 in GCT and other tumor types using immunohistochemistry. The protein was consistently detected in carcinoma in situ/gonadoblastoma, seminomas/germinoma/dysgerminoma, and embryonal carcinoma but not in the various types of differentiated nonseminomas. Multitumor tissue microarray analysis covering >100 different tumor categories and 3600 individual cancers verified that POU5F1 expression is specific for particular subtypes of GCT of adults. No protein was observed in GCT of newborn and infants, spermatocytic seminomas, and the various tumors of nongerm cell origin. In addition, no difference in staining pattern was found in chemosensitive and chemoresistant GCT of adults. These results indicate preservation of the link between POU5F1 and pluripotency, as reported during normal development, after malignant transformation. Therefore, POU5F1 immunohistochemistry is an informative diagnostic tool for pluripotent GCT and offers new insights into the histological heterogeneity of this cancer.
Similar articles
-
OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.
Cheng L, Sung MT, Cossu-Rocca P, Jones TD, MacLennan GT, De Jong J, Lopez-Beltran A, Montironi R, Looijenga LH. Cheng L, et al. J Pathol. 2007 Jan;211(1):1-9. doi: 10.1002/path.2105. J Pathol. 2007. PMID: 17117392 Review.
-
Looijenga LH, Gillis AJ, Stoop HJ, Hersmus R, Oosterhuis JW. Looijenga LH, et al. Ann N Y Acad Sci. 2007 Dec;1120:187-214. doi: 10.1196/annals.1411.000. Epub 2007 Oct 2. Ann N Y Acad Sci. 2007. PMID: 17911410 Review.
-
Wermann H, Stoop H, Gillis AJ, Honecker F, van Gurp RJ, Ammerpohl O, Richter J, Oosterhuis JW, Bokemeyer C, Looijenga LH. Wermann H, et al. J Pathol. 2010 Aug;221(4):433-42. doi: 10.1002/path.2725. J Pathol. 2010. PMID: 20593487
-
Honecker F, Kersemaekers AM, Molier M, Van Weeren PC, Stoop H, De Krijger RR, Wolffenbuttel KP, Oosterhuis W, Bokemeyer C, Looijenga LH. Honecker F, et al. J Pathol. 2004 Oct;204(2):167-74. doi: 10.1002/path.1614. J Pathol. 2004. PMID: 15378486
Cited by
-
Functional OCT4-specific CD4+ and CD8+ T cells in healthy controls and ovarian cancer patients.
Di J, Massuger LF, Duiveman-de Boer T, Zusterzeel PL, Figdor CG, Torensma R. Di J, et al. Oncoimmunology. 2013 May 1;2(5):e24271. doi: 10.4161/onci.24271. Epub 2013 Apr 1. Oncoimmunology. 2013. PMID: 23762805 Free PMC article.
-
Adler-Wailes DC, Kramer JA, DePamphilis ML. Adler-Wailes DC, et al. Stem Cells Dev. 2017 Feb 15;26(4):285-302. doi: 10.1089/scd.2016.0260. Epub 2016 Nov 7. Stem Cells Dev. 2017. PMID: 27821018 Free PMC article.
-
Morphological approach to tumours of the testis and paratestis.
Emerson RE, Ulbright TM. Emerson RE, et al. J Clin Pathol. 2007 Aug;60(8):866-80. doi: 10.1136/jcp.2005.036475. Epub 2007 Feb 16. J Clin Pathol. 2007. PMID: 17307866 Free PMC article. Review.
-
Rajpert-De Meyts E, Poll SN, Goukasian I, Jeanneau C, Herlihy AS, Bennett EP, Skakkebaek NE, Clausen H, Giwercman A, Mandel U. Rajpert-De Meyts E, et al. Virchows Arch. 2007 Oct;451(4):805-14. doi: 10.1007/s00428-007-0478-4. Epub 2007 Aug 11. Virchows Arch. 2007. PMID: 17694322
-
Knežević N, Kuliš T, Penezić L, Ćorić M, Krhen I, Kaštelan Ž. Knežević N, et al. Acta Clin Croat. 2019 Jun;58(2):343-347. doi: 10.20471/acc.2019.58.02.19. Acta Clin Croat. 2019. PMID: 31819332 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources